There were 1,178 press releases posted in the last 24 hours and 199,292 in the last 365 days.

Aequus to Present at Bloom Burton & Co. Healthcare Investor Conference


/EINPresswire.com/ -- VANCOUVER, BC--(Marketwired - April 26, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today announced that its Chairman and Chief Executive Officer, Doug Janzen, will present at the fifth annual Bloom Burton & Co. Healthcare Investor Conference on Monday May 2nd, 2016 at 3:00pm Eastern Standard Time at the Sheraton Centre Toronto Hotel in Toronto, Ontario.

About Aequus Pharmaceuticals

Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) is a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus' sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including neurology, ophthalmology and transplant. Aequus is developing a pipeline of products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide. For further information, please visit www.aequuspharma.ca

About the Bloom Burton & Co. Healthcare Investor Conference

The conference will host approximately 60 of Canada's premier publicly traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare industry. The event will attract Canadian, U.S. and International investors who are interested in the latest developments in Canadian healthcare companies. Investors will have the opportunity to obtain corporate updates from presenting companies, and participate in 1-on-1 meeting system with company management.

Contact Information

Aequus Investor Relations
Email: investors@aequuspharma.ca
Phone: 604-428-4641


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.